Health
CN Bio and the University of Melbourne collaborate to advance therapies for respiratory complications in recovered COVID-19 patients – News-Medical.Net
CN Bio, a leading cell culture company, that has developed single and multi-organ microphysiological systems (MPS) to improve the accuracy and efficiency of drug…
CN Bio, a leading cell culture company, that has developed single and multi-organ microphysiological systems (MPS) to improve the accuracy and efficiency of drug discovery, today announced a collaboration with the University of Melbourne, focused on respiratory therapies for recovering COVID-19 patients.
Harnessing CN Bio’s Organ-on-a-Chip technology, the aim of the research is to develop a model capable of recapitulating the fibrosis and tissue remodeling seen in chronic interstitial lung disease,…
-
General23 hours agoDash cam video shows spectacular Finke Desert Race crash
-
Business23 hours agoWhy I’d buy these top ASX 200 shares next
-
Noosa News18 hours agoAre speeding fines suitability issues? – Proctor
-
Noosa News22 hours agoDocPlay Is Streaming 11 Documentaries About Indigenous and Torres Strait Islander Culture for Free for NAIDOC Week 2025